Pancreatic cancer (PC) is a deadly disease, and its post‐transcriptional gene regulation
mechanism remains unclear. The abundant extracellular matrix (ECM) in PC plays an …

Pancreatic cancer (PC) is one of the most fatal cancers with a very poor prognosis. Here, we
found that N6-methyladenosine (m6A) RNA demethylase fat mass and obesity-related …

Abstract RNA N6-methyladenosine (m6A) is an emerging regulator of mRNA modifications
and represents a novel player in tumorigenesis. Although it has functional significance in …

Background Pancreatic cancer is one of the most lethal human cancers. N 6-
methyladenosine (m 6 A), a common eukaryotic mRNA modification, plays critical roles in …

Background Pancreatic carcinoma (PC) is a highly lethal cancer with an increasing mortality
rate, its five‐year survival rate is only approximately 4%. N6‐methyladenosine (m6A) …

Pancreatic cancer is a formidable cause of cancer-related deaths worldwide and has
witnessed a more than twofold increase in incidence over the last 25 years. The most …

Pancreatic cancer (PC) has a very poor prognosis and is usually diagnosed only at an
advanced stage. The discovery of new biomarkers for PC will help in early diagnosis and a …

Accumulating evidence indicates that RNA methylation at N 6-methyladenosine (m6A) plays
an important regulatory role in gene expression and aberrant mRNA m6A modification is …

Background Pancreatic cancer is a fatal malignancy of the digestive system and the 5-year
survival rate remains low. Therefore, new molecular therapeutic targets are required to …

Abstract Background N6-methyladenosine (m6A) modification is the most pervasive
modification in mRNA, and has been considered as a new layer of epigenetic regulation on …